Ginkgo Bioworks acquired biotechnology firm Zymergen, the synthetic biology companies announced Monday morning, marking the final act in Zymergen’s dramatic and brisk fall from grace. Signage is ...

Shares of Zymergen soared as much as 85% on Thursday, helping the synthetic biology company recoup some of its massive losses from Wednesday. Zymergen plunged 76% yesterday after it said issues with ...

Less than four months after going public and being valued at more than $3 billion by Wall Street, Zymergen Inc. unleashed some bad news Tuesday afternoon, and was on pace to lose more than two-thirds ...

EMERYVILLE — Zymergen has struck a deal for a big new Emeryville campus that will provide plenty of elbow room for the maker of microbes used by Corporate America and overseas companies. Potentially, ...

Continuing the roller-coaster ride that it has been on this week, shares of Zymergen (NASDAQ: ZY) are plummeting Friday. As of 11:12 a.m. EDT, the stock was down by 14.1%. Two changes in the synthetic ...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Today Zymergen is launching Hyaline, a revolutionary new film for electronics applications. This breakthrough bio-manufactured product has successfully been used ...